DOES AUTO TRANSFUSION OF UNPROCESSED RESIDUAL BLOOD IN THE CARDIOPULMONARY BYPASS CIRCUIT LEAD TO UNFAVORABLE OUTCOMES?
ABSTRACT Objective: Transfusion of residual blood left in the cardiopulmonary bypass circuit is recommended. Whether this blood should be processed or not before transfusion is not known. Study Design: A prospective non-randomized case control study. Place and Duration of Study: A tertiary care hear...
Gespeichert in:
Veröffentlicht in: | Pakistan Armed Forces medical journal 2020-12, Vol._ (6), p.S819 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 6 |
container_start_page | S819 |
container_title | Pakistan Armed Forces medical journal |
container_volume | _ |
creator | Siddiqeh, Musfireh Khan, Imran Ali Gohar Zamir Asif Mehmood Janjua Munir, Beenish Anjum, Qudsia |
description | ABSTRACT Objective: Transfusion of residual blood left in the cardiopulmonary bypass circuit is recommended. Whether this blood should be processed or not before transfusion is not known. Study Design: A prospective non-randomized case control study. Place and Duration of Study: A tertiary care heart center, from Jan 2016 to Dec 2018. Methodology: A prospective non-randomized case control study was designed. Consecutive patients operated at a tertiary care hospital were included in the study who underwent different open-heart procedures on cardiopulmonary bypass. Patients were divided into two groups. Those who received the unprocessed residual blood transfusion, residual volume retransfused at the end of cardiopulmonary bypass and those who did not, residual volume not retransfused (RVNR). Important perioperative data was collected from the hospital database and analyzed using IBM SPSS-statistics 23.0 (IBM, SPSS Inc., Chicago, IL). Results: Of the 120 patients, 56 patients were included in the RVR group and 64 in the RVNR group. Mean age in the RVR group was 49.41 ± 14.38 years and in the RVNR group 49.27 ± 16.36 years (p=0.96). Female patients were 9 (16.07%) in the RVR group and 20 (31.25%) in the RVNR group. Residual blood left in the circuit was 271.43 ± 52 ml in the RVR group and 264.06 ± 54.5 ml in the RVNR group (p=0.45). Hemoglobin measured in ICU was 10.5 ± 1.12 gm/dl in the RVR group and 9.97 ± 1.25 gm/dl in the RVNR group (0.02). Blood products were needed in 27 patients in RVR group and 21 patients in RVNR group (p=0.57). There was no significant difference between the two groups with respect to total drainage in the first 24 hours (p=0.89). Similarly, the re-exploration rates were not different between the two groups (p=0.50). Conclusion: Re-transfusion of residual blood left in the CPB circuit is a safe practiced. If this blood is transfused in an unprocessed form, it does not lead to adverse outcomes. |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_2475067640</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A648998912</galeid><sourcerecordid>A648998912</sourcerecordid><originalsourceid>FETCH-LOGICAL-g950-849e628e1426bb9dd91ba9da328478a45297ae7f95dd56e71f2b3e4cc73094873</originalsourceid><addsrcrecordid>eNptkF9rgzAUxWVssNL1OwT27IgxmuRppDGugjXFmEGfxD-xWNq61ZZ-_QkbbA-79-HA4XfPgXvnzBD2PJdSjO6dGYQ-dFmI6aOzGMc9nCbwEYbBzLlFSmrATaFAkfNMx0YnKgMqBibb5EpIrWUEcqmTyPAULFOlIpBkoFhJIHgeJWpj0rXKeL4Fy-2Gaw1EkguTFCCVPAJTrsli_q5yvkwlUKYQai3165Pz0FWH0S5-dO4UsSzEyk3VWyJ46u5YAF2KmQ0RtR5GYV2ztmVeXbG28hHFhFY4QIxUlnQsaNsgtMTrUO1b3DTEhwxT4s-d5-_Yj_PwebXjpdwP1_NpaiwRJgEMSYjhL7WrDrbsT91wOVfNsR-bkk9fY4wyD03Uyz_UtK099s1wsl0_-X8OvgC5a2pV</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2475067640</pqid></control><display><type>article</type><title>DOES AUTO TRANSFUSION OF UNPROCESSED RESIDUAL BLOOD IN THE CARDIOPULMONARY BYPASS CIRCUIT LEAD TO UNFAVORABLE OUTCOMES?</title><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Siddiqeh, Musfireh ; Khan, Imran ; Ali Gohar Zamir ; Asif Mehmood Janjua ; Munir, Beenish ; Anjum, Qudsia</creator><creatorcontrib>Siddiqeh, Musfireh ; Khan, Imran ; Ali Gohar Zamir ; Asif Mehmood Janjua ; Munir, Beenish ; Anjum, Qudsia</creatorcontrib><description>ABSTRACT Objective: Transfusion of residual blood left in the cardiopulmonary bypass circuit is recommended. Whether this blood should be processed or not before transfusion is not known. Study Design: A prospective non-randomized case control study. Place and Duration of Study: A tertiary care heart center, from Jan 2016 to Dec 2018. Methodology: A prospective non-randomized case control study was designed. Consecutive patients operated at a tertiary care hospital were included in the study who underwent different open-heart procedures on cardiopulmonary bypass. Patients were divided into two groups. Those who received the unprocessed residual blood transfusion, residual volume retransfused at the end of cardiopulmonary bypass and those who did not, residual volume not retransfused (RVNR). Important perioperative data was collected from the hospital database and analyzed using IBM SPSS-statistics 23.0 (IBM, SPSS Inc., Chicago, IL). Results: Of the 120 patients, 56 patients were included in the RVR group and 64 in the RVNR group. Mean age in the RVR group was 49.41 ± 14.38 years and in the RVNR group 49.27 ± 16.36 years (p=0.96). Female patients were 9 (16.07%) in the RVR group and 20 (31.25%) in the RVNR group. Residual blood left in the circuit was 271.43 ± 52 ml in the RVR group and 264.06 ± 54.5 ml in the RVNR group (p=0.45). Hemoglobin measured in ICU was 10.5 ± 1.12 gm/dl in the RVR group and 9.97 ± 1.25 gm/dl in the RVNR group (0.02). Blood products were needed in 27 patients in RVR group and 21 patients in RVNR group (p=0.57). There was no significant difference between the two groups with respect to total drainage in the first 24 hours (p=0.89). Similarly, the re-exploration rates were not different between the two groups (p=0.50). Conclusion: Re-transfusion of residual blood left in the CPB circuit is a safe practiced. If this blood is transfused in an unprocessed form, it does not lead to adverse outcomes.</description><identifier>ISSN: 0030-9648</identifier><identifier>EISSN: 2411-8842</identifier><language>eng</language><publisher>Rawalpindi: Knowledge Bylanes</publisher><subject>Anticoagulants (Medicine) ; Biological products ; Blood transfusion ; Coronary artery bypass ; Decision making ; Dentists ; Eye contact ; Habitus ; Interviews ; Knowledge ; Language ; Medical research ; Patients ; Physicians ; Power ; Researchers ; Trust</subject><ispartof>Pakistan Armed Forces medical journal, 2020-12, Vol._ (6), p.S819</ispartof><rights>COPYRIGHT 2020 Knowledge Bylanes</rights><rights>(c)2020 Pakistan Armed Forces Medical Journal</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Siddiqeh, Musfireh</creatorcontrib><creatorcontrib>Khan, Imran</creatorcontrib><creatorcontrib>Ali Gohar Zamir</creatorcontrib><creatorcontrib>Asif Mehmood Janjua</creatorcontrib><creatorcontrib>Munir, Beenish</creatorcontrib><creatorcontrib>Anjum, Qudsia</creatorcontrib><title>DOES AUTO TRANSFUSION OF UNPROCESSED RESIDUAL BLOOD IN THE CARDIOPULMONARY BYPASS CIRCUIT LEAD TO UNFAVORABLE OUTCOMES?</title><title>Pakistan Armed Forces medical journal</title><description>ABSTRACT Objective: Transfusion of residual blood left in the cardiopulmonary bypass circuit is recommended. Whether this blood should be processed or not before transfusion is not known. Study Design: A prospective non-randomized case control study. Place and Duration of Study: A tertiary care heart center, from Jan 2016 to Dec 2018. Methodology: A prospective non-randomized case control study was designed. Consecutive patients operated at a tertiary care hospital were included in the study who underwent different open-heart procedures on cardiopulmonary bypass. Patients were divided into two groups. Those who received the unprocessed residual blood transfusion, residual volume retransfused at the end of cardiopulmonary bypass and those who did not, residual volume not retransfused (RVNR). Important perioperative data was collected from the hospital database and analyzed using IBM SPSS-statistics 23.0 (IBM, SPSS Inc., Chicago, IL). Results: Of the 120 patients, 56 patients were included in the RVR group and 64 in the RVNR group. Mean age in the RVR group was 49.41 ± 14.38 years and in the RVNR group 49.27 ± 16.36 years (p=0.96). Female patients were 9 (16.07%) in the RVR group and 20 (31.25%) in the RVNR group. Residual blood left in the circuit was 271.43 ± 52 ml in the RVR group and 264.06 ± 54.5 ml in the RVNR group (p=0.45). Hemoglobin measured in ICU was 10.5 ± 1.12 gm/dl in the RVR group and 9.97 ± 1.25 gm/dl in the RVNR group (0.02). Blood products were needed in 27 patients in RVR group and 21 patients in RVNR group (p=0.57). There was no significant difference between the two groups with respect to total drainage in the first 24 hours (p=0.89). Similarly, the re-exploration rates were not different between the two groups (p=0.50). Conclusion: Re-transfusion of residual blood left in the CPB circuit is a safe practiced. If this blood is transfused in an unprocessed form, it does not lead to adverse outcomes.</description><subject>Anticoagulants (Medicine)</subject><subject>Biological products</subject><subject>Blood transfusion</subject><subject>Coronary artery bypass</subject><subject>Decision making</subject><subject>Dentists</subject><subject>Eye contact</subject><subject>Habitus</subject><subject>Interviews</subject><subject>Knowledge</subject><subject>Language</subject><subject>Medical research</subject><subject>Patients</subject><subject>Physicians</subject><subject>Power</subject><subject>Researchers</subject><subject>Trust</subject><issn>0030-9648</issn><issn>2411-8842</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNptkF9rgzAUxWVssNL1OwT27IgxmuRppDGugjXFmEGfxD-xWNq61ZZ-_QkbbA-79-HA4XfPgXvnzBD2PJdSjO6dGYQ-dFmI6aOzGMc9nCbwEYbBzLlFSmrATaFAkfNMx0YnKgMqBibb5EpIrWUEcqmTyPAULFOlIpBkoFhJIHgeJWpj0rXKeL4Fy-2Gaw1EkguTFCCVPAJTrsli_q5yvkwlUKYQai3165Pz0FWH0S5-dO4UsSzEyk3VWyJ46u5YAF2KmQ0RtR5GYV2ztmVeXbG28hHFhFY4QIxUlnQsaNsgtMTrUO1b3DTEhwxT4s-d5-_Yj_PwebXjpdwP1_NpaiwRJgEMSYjhL7WrDrbsT91wOVfNsR-bkk9fY4wyD03Uyz_UtK099s1wsl0_-X8OvgC5a2pV</recordid><startdate>20201231</startdate><enddate>20201231</enddate><creator>Siddiqeh, Musfireh</creator><creator>Khan, Imran</creator><creator>Ali Gohar Zamir</creator><creator>Asif Mehmood Janjua</creator><creator>Munir, Beenish</creator><creator>Anjum, Qudsia</creator><general>Knowledge Bylanes</general><general>AsiaNet Pakistan (Pvt) Ltd</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20201231</creationdate><title>DOES AUTO TRANSFUSION OF UNPROCESSED RESIDUAL BLOOD IN THE CARDIOPULMONARY BYPASS CIRCUIT LEAD TO UNFAVORABLE OUTCOMES?</title><author>Siddiqeh, Musfireh ; Khan, Imran ; Ali Gohar Zamir ; Asif Mehmood Janjua ; Munir, Beenish ; Anjum, Qudsia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g950-849e628e1426bb9dd91ba9da328478a45297ae7f95dd56e71f2b3e4cc73094873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Anticoagulants (Medicine)</topic><topic>Biological products</topic><topic>Blood transfusion</topic><topic>Coronary artery bypass</topic><topic>Decision making</topic><topic>Dentists</topic><topic>Eye contact</topic><topic>Habitus</topic><topic>Interviews</topic><topic>Knowledge</topic><topic>Language</topic><topic>Medical research</topic><topic>Patients</topic><topic>Physicians</topic><topic>Power</topic><topic>Researchers</topic><topic>Trust</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Siddiqeh, Musfireh</creatorcontrib><creatorcontrib>Khan, Imran</creatorcontrib><creatorcontrib>Ali Gohar Zamir</creatorcontrib><creatorcontrib>Asif Mehmood Janjua</creatorcontrib><creatorcontrib>Munir, Beenish</creatorcontrib><creatorcontrib>Anjum, Qudsia</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Pakistan Armed Forces medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Siddiqeh, Musfireh</au><au>Khan, Imran</au><au>Ali Gohar Zamir</au><au>Asif Mehmood Janjua</au><au>Munir, Beenish</au><au>Anjum, Qudsia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>DOES AUTO TRANSFUSION OF UNPROCESSED RESIDUAL BLOOD IN THE CARDIOPULMONARY BYPASS CIRCUIT LEAD TO UNFAVORABLE OUTCOMES?</atitle><jtitle>Pakistan Armed Forces medical journal</jtitle><date>2020-12-31</date><risdate>2020</risdate><volume>_</volume><issue>6</issue><spage>S819</spage><pages>S819-</pages><issn>0030-9648</issn><eissn>2411-8842</eissn><abstract>ABSTRACT Objective: Transfusion of residual blood left in the cardiopulmonary bypass circuit is recommended. Whether this blood should be processed or not before transfusion is not known. Study Design: A prospective non-randomized case control study. Place and Duration of Study: A tertiary care heart center, from Jan 2016 to Dec 2018. Methodology: A prospective non-randomized case control study was designed. Consecutive patients operated at a tertiary care hospital were included in the study who underwent different open-heart procedures on cardiopulmonary bypass. Patients were divided into two groups. Those who received the unprocessed residual blood transfusion, residual volume retransfused at the end of cardiopulmonary bypass and those who did not, residual volume not retransfused (RVNR). Important perioperative data was collected from the hospital database and analyzed using IBM SPSS-statistics 23.0 (IBM, SPSS Inc., Chicago, IL). Results: Of the 120 patients, 56 patients were included in the RVR group and 64 in the RVNR group. Mean age in the RVR group was 49.41 ± 14.38 years and in the RVNR group 49.27 ± 16.36 years (p=0.96). Female patients were 9 (16.07%) in the RVR group and 20 (31.25%) in the RVNR group. Residual blood left in the circuit was 271.43 ± 52 ml in the RVR group and 264.06 ± 54.5 ml in the RVNR group (p=0.45). Hemoglobin measured in ICU was 10.5 ± 1.12 gm/dl in the RVR group and 9.97 ± 1.25 gm/dl in the RVNR group (0.02). Blood products were needed in 27 patients in RVR group and 21 patients in RVNR group (p=0.57). There was no significant difference between the two groups with respect to total drainage in the first 24 hours (p=0.89). Similarly, the re-exploration rates were not different between the two groups (p=0.50). Conclusion: Re-transfusion of residual blood left in the CPB circuit is a safe practiced. If this blood is transfused in an unprocessed form, it does not lead to adverse outcomes.</abstract><cop>Rawalpindi</cop><pub>Knowledge Bylanes</pub><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0030-9648 |
ispartof | Pakistan Armed Forces medical journal, 2020-12, Vol._ (6), p.S819 |
issn | 0030-9648 2411-8842 |
language | eng |
recordid | cdi_proquest_journals_2475067640 |
source | DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals |
subjects | Anticoagulants (Medicine) Biological products Blood transfusion Coronary artery bypass Decision making Dentists Eye contact Habitus Interviews Knowledge Language Medical research Patients Physicians Power Researchers Trust |
title | DOES AUTO TRANSFUSION OF UNPROCESSED RESIDUAL BLOOD IN THE CARDIOPULMONARY BYPASS CIRCUIT LEAD TO UNFAVORABLE OUTCOMES? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T03%3A31%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=DOES%20AUTO%20TRANSFUSION%20OF%20UNPROCESSED%20RESIDUAL%20BLOOD%20IN%20THE%20CARDIOPULMONARY%20BYPASS%20CIRCUIT%20LEAD%20TO%20UNFAVORABLE%20OUTCOMES?&rft.jtitle=Pakistan%20Armed%20Forces%20medical%20journal&rft.au=Siddiqeh,%20Musfireh&rft.date=2020-12-31&rft.volume=_&rft.issue=6&rft.spage=S819&rft.pages=S819-&rft.issn=0030-9648&rft.eissn=2411-8842&rft_id=info:doi/&rft_dat=%3Cgale_proqu%3EA648998912%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2475067640&rft_id=info:pmid/&rft_galeid=A648998912&rfr_iscdi=true |